Abstract
The absorption enhancing effect of methylated β-cyclodextrins on the nasal absorption of salmon calcitonin (sCT) was studied in rats and rabbits. The nasal absorption of sCT following administration without additives was low in both species. The absorption in rats could be largely improved by coadministration of cyclodextrins as apparent from the effect on serum calcium concentrations. Trimethyl-β-cyclodextrin (TMβCD), at a concentration of 5% (w/v), was the least potent enhancer. Randomly methylated-β-cyclodextrin (RMβCD) and dimethyl-β-cyclodextrin (DMβCD), all at a concentration of 5% (w/v), were almost equally effective in decreasing serum calcium levels, and the hypocalcemic responses were similar to those of i.v. and s.c. injected sCT. Absorption enhancement was already achieved with 1% DMβCD added to the nasal formulations. In rabbits, only the effect of DMβCD on the nasal sCT absorption was investigated. A total serum calcium decrement in 4 hours of 9.4±3.9% (mean±SD) was observed following nasal administration of 12.6 IU/kg sCT with 5% DMβCD, comparable to that of i.v.-injected sCT. In conclusion, the methylated cyclodextrins DMβCD and RMβCD are suitable absorption enhancers for nasal sCT administration, which is expected to have a clinical impact on the therapy with calcitonin.
Similar content being viewed by others
References
Azria M (1989) The calcitonins: physiology and pharmacology. Karger, Basel
McDermott MT, Kidd GS (1987) The role of calcitonin in the development and treatment of osteoporosis. Endocrinol Rev 8:377–390
Nagant de Deuxchaisnes C, Devogelaer JP, Haux JP, Dufour JP, Esselinckx W, Engelbeen JP, Stasse P, Hermans P, De Buisseret JP (1987) New modes of administration of salmon calcitonin in Paget's disease. Clin Orthop 217:56–71
Chien YW, Su KSE, Chang SF (1989) Nasal systemic drug delivery. Marcel Dekker, New York
Reginster JY, Franchimont P (1985) Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin Exp Rheumatol 3:155–157
Reginster JY, Alber A, Lecart MP, Lambelin P, Denis P, Deroisy R, Fontaine MA, Franchimont P (1987) 1-Year controlled randomised trial of prevention of early post-menopausal bone loss by intranasal calcitonin. Lancet 1481–1483
Overgaard K, Angusdei D, Hansen MA, Maioli E, Christiansen C, Gennari C (1991) Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women. J Clin Endocrinol Metab 72:344–349
Rico H, Hernandez ER, Diaz-Mediavilla J, Alvarez A, Martinez R, Espinos D (1990) Treatment of multiple myeloma with nasal spray calcitonin: a histomorphometric and biochemical study. Bone Miner 8:231–237
Rizzato G, Schiraldi G, Tosi G, Locicero S, Montemurro L, Zanni D, Sisti S (1989) Administration of salmon calcitonin nasal spray for long-term treatment of corticosteroid-induced osteoporosis. Curr Ther Res 45:761–767
Merkus FWHM, Verhoef J, Romeijn SG, Schipper NGM (1991) Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm Res 8:588–592
Schipper NGM, Verhoef JC, De Lannoy LM, Romeijn SG, Brakkee JH, Wiegant VM, Gispen WH, Merkus FWHM (1993) Nasal administration of an ACTH(4–9) peptide analogue with dimethyl-β-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics. Br J Pharmacol 110:1335–1340
Merkus FWHM, Schipper NGM, Hermens WAJJ, Romeijn SG, Verhoef J (1993) Absorption enhancers in nasal drug delivery: efficacy and safety. J Controlled Rel 24:201–208
Morimoto K, Miyazaki M, Yamaguchi H, Kakemi M (1992) Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin, an analogue and calcitonin. Proc Intern Symp Control Rel Bioact Mater 19:218–219
Hanson M, Gazdick G, Cahill J, Augustine M (1986) Intranasal delivery of the peptide salmon calcitonin. In: Davis SS, Illum L, Tomlinson E (eds) Delivery systems for peptide drugs. Plenum Press, New York, pp 233–242
Irie T, Wakamatsu K, Arima H, Aritoma H, Uekama K (1992) Enhancing effects of cyclodextrins on nasal absorption of insulin in rats. Int J Pharmaceutics 84:129–139
Lee ML, Chien YW (1991) Degradation of calcitonin in buffered solution and various mucosal extracts. Pharmaceutical Res 8:S49
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schipper, N.G.M., Verhoef, J.C., Romeijn, S.G. et al. Methylated β-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif Tissue Int 56, 280–282 (1995). https://doi.org/10.1007/BF00318047
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00318047